Parents Shocked by Price of Children’s Hormone Drug
The parents of an 8-year-old girl were shocked when they discovered the price for a children's hormone blocker cost about [...]
Blog Post Highlights Tool for Tracking Low-Value Care Spending
A recent PhRMA blog post highlights a new web-based tool by the Research Consortium for Health Care Value Assessment that [...]
ICER Releases Final Report on Acute Treatments for Migraine
The Institute for Clinical and Economic Review (ICER) on Tuesday, Feb. 25, released its final report on three acute treatments [...]
AHIP: MCO’s Generated $6.5 Billion in Medicaid Savings in 2018
A new report by America's Health Insurance Plans (AHIP) suggests managed care organizations were able to save Medicaid programs roughly [...]
Veradigm Highlights Social Determinants of Health in New White Paper
Veradigm, a health information technology, analytics and intervention solutions company, in a new tHEORetically Speaking blog post highlights its new [...]
ICER Announces RWE Partnership with Aetion
The Institute for Clinical and Economic Review (ICER) is partnering with Aetion to "generate decision-grade real-world evidence," the drug pricing [...]
PhRMA: HCCI Report ‘Overestimates Medicine Spending and Pricing’
The Health Care Cost Institute's (HCCI) recent report on health spending "overestimates medicine spending and pricing and mischaracterizes the true [...]
PBM Report Suggests Wider Use of Tools Can Lead to $1 Trillion in Savings
A new study by Visante, funded by the Pharmaceutical Care Management Association (PCMA), suggests greater use of PBM tools could [...]
Pearson: Program to Bolster Patient Involvement in Review Process
The Institute for Clinical and Economic Review's (ICER) new Patient Engagement Program is a big leap forward for the drug [...]
Tufts’ Cohen Highlights ICER’s Third Value Assessment Framework
Tufts Medical Center's Joshua Cohen, deputy director of the Center for the Evaluation of Value and Risk in Health, in [...]
Analysis Looks at ICER’s FDA Outreach Plan
A recent analysis by the Pink Sheet spotlights a new initiative by the Institute for Clinical and Economic Review (ICER) [...]
ICER Plans Review of Bladder Cancer Treatment
The Institute for Clinical and Economic Review (ICER) announced plans to review FKD Therapies Oy and Ferring Pharmaceuticals' Instiladrin for [...]
ICER Releases Draft Report on Cystic Fibrosis Therapies
The Institute for Clinical and Economic Review (ICER) on Thursday, Feb. 20, released a draft evidence report on treatments for [...]
Article Highlights Digital Healthcare Ecosystem
HEOR researcher and scientific writer Michele Cleary in the latest Value & Outcomes Spotlight featured article offers expert perspectives on [...]
Survey: More than Half of Patients Avoid Taking Medicine Due to Cost
A recent survey conducted by Surescripts, in partnership with Engine Group, suggests a little more than half of U.S. patients [...]
CMS Testing Waters with Risk-Sharing Deals with ACO Program
The Centers for Medicare and Medicaid Services (CMS) is testing risk-sharing agreements in Medicare's Direct Contracting program, according to a [...]
Blog Post: Making the Most of Our Health Care Dollars
A recent blog post on Going Below the Surface highlights a panel discussion during AcademyHealth National Health Policy Conference that [...]
3M Announces Webinar Series for Health Plans
3M this week announced a new webinar series developed specifically for health care plans. The first webinar in the series, [...]
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic Platform, hēRo3
Policy Analysis Inc. (PAI), a Boston-based health-economics consultancy, on Wednesday, Feb. 19, announced that it had signed a multi-year deal [...]
Article Reflects on NICE’s Achievements, Economic Evaluation Methods
University of York's Mark Sculpher and Stephen Palmer in a recent article published in PharmacoEconomics discuss the National Institute for [...]
COTA White Paper Spotlights Perspectives on RWE
A new white paper from COTA offers unique perspectives on real-world evidence (RWE), including input from Pfizer and Bristol-Myers Squibb [...]
ISPOR Launches International Search for New Editor-in-Chief of Value & Outcomes Spotlight Magazine
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is launching an international search for a new editor-in-chief for its [...]
Lown Institute’s Saini, Brownlee Talk Shkreli Awards
Lown Institute's Vikas Saini, president, and Shannon Brownlee, senior vice president, discuss the latest Shkreli Awards winners on the Relentless [...]
Randomization vs. Real-World Evidence
Nonrandomized observational studies have been touted by some as being a viable alternative to randomized clinical trials, but are they [...]
Massachusetts to Pay for Zolgensma on One Condition: It Must Work
Massachusetts' Medicaid program, MassHealth, has inked a conditional deal for Novartis' $2 million one-time spinal muscular atrophy (SMA) gene therapy, [...]